Whey peptides

Whey protein hydrolysate peptides, lactokinins (ACE-inhibitory whey peptides), glycomacropeptide (GMP, caseinomacropeptide, CMP), α-lactorphin, β-lactorphin, lactoferricin (from lactoferrin)

Food-derived & nutrition

Awaiting medical reviewEN ES DE FR PT ZH+ Follow for updates

Summary

Class: Food-derived peptide fractions released from whey proteins (β-lactoglobulin, α-lactalbumin, lactoferrin, κ-casein tail) during cheesemaking, enzymatic hydrolysis or digestion
Mechanism: Different fragments do different things: some inhibit ACE (blood-pressure enzyme), some stimulate insulin and GLP-1, some act as weak opioid or antimicrobial peptides; GMP is a phenylalanine-free protein source
Routes studied: Oral (hydrolysate powders, medical foods, fortified drinks)
Dose range reported: Human trials: whey protein hydrolysate 10–50 g/day; ACE-inhibitory whey fractions 0.5–3 g/day (e.g. NOP-47 studied at ~5 g); GMP as medical food ~0.5–1 g protein-equivalent/kg/day in PKU, i.e. 20–60 g/day. Typical consumer whey servings 20–30 g
Half-life: Minutes to hours; most whey peptides are hydrolysed by gut and plasma peptidases, which is a key reason isolated peptide effects are modest
Storage: Dry powders: room temperature, sealed. Mixed drinks: refrigerate, consume within a day
Regulatory status: Food ingredients and supplements; GMP-based products are regulated medical foods for PKU

Doses are as reported in studies or by the community — never recommendations.

1What it is

Whey is the liquid left when milk curdles. Its proteins contain, folded inside them, dozens of short sequences that become active once released by digestion or deliberate enzymatic hydrolysis. These are collectively called whey-derived bioactive peptides. The best characterised are: - Lactokinins — ACE-inhibitory peptides from β-lactoglobulin and α-lactalbumin (e.g. Ala-Leu-Pro-Met-His-Ile-Arg). - Glycomacropeptide (GMP) — the 64-amino-acid glycosylated tail of κ-casein that ends up in whey during cheesemaking. It is technically casein-derived but is sold as a whey fraction. It contains no phenylalanine, tryptophan or tyrosine, which makes it uniquely useful in phenylketonuria (PKU). - Lactorphins — short opioid-like peptides. - Lactoferricin — an antimicrobial fragment of lactoferrin. All are natural food constituents, not synthetic compounds. Whole whey protein as a muscle-building supplement is a separate topic; this profile focuses on the peptide-specific claims.

2How it's thought to work

ACE inhibition. lactokinins inhibit angiotensin-converting enzyme , which in principle lowers blood pressure (FitzGerald & Meisel 2000). In practice they must survive digestion and reach the blood in meaningful amounts, which is uncertain.

Incretin and insulin effects. whey hydrolysates raise GLP-1 and GIP and stimulate insulin more than intact whey, partly through rapid delivery of leucine and partly through inhibition of DPP-4 by specific dipeptides (Nilsson 2004; Jakubowicz 2014).

Muscle protein synthesis. rapid absorption of leucine-rich peptides; the effect is from amino-acid delivery rather than from peptides acting as signals.

GMP. works nutritionally (a near-complete, phenylalanine-free protein) and may also have satiety and prebiotic effects via sialic-acid residues.

Lactoferricin. disrupts bacterial membranes in vitro; human relevance unclear.

Whey protein broken into fragments that are absorbed faster than the intact protein. The muscle effect is attributed to the leucine it delivers rather than to any peptide signal.Schematic — not to scale

3What the research shows

Graded A (acute studies)

Post-meal glucose and insulin

Whey protein or hydrolysate taken before or with a carbohydrate meal lowers post-meal glucose and raises insulin and GLP-1 in healthy people and people with type 2 diabetes (Frid 2005, Am J Clin Nutr; Jakubowicz 2014, Diabetologia — 50 g whey "preload"). Effects are acute; long-term glycaemic trials are small and mixed. [3][4]

Graded A/B (small, mixed)

Blood pressure

A 6-week trial of a whey-derived ACE-inhibitory fraction reported reductions in systolic and diastolic pressure in young adults with elevated BP (Pal & Ellis 2010, Obesity — whole whey protein, 54 g/day; Fluegel 2010, Int Dairy J — whey fraction). Other trials are null. Overall effect small (a few mmHg) and not robust enough for regulators: EFSA has not authorised blood-pressure claims for whey peptides. [5]

Glycomacropeptide in phenylketonuria

GMP-based medical foods (supplemented with the missing amino acids) achieve acceptable blood phenylalanine control, improve acceptability and may improve some nutritional and bone markers compared with amino-acid formula (van Calcar 2009, Am J Clin Nutr; Ney 2016, J Inherit Metab Dis — randomised crossover, 30 participants). Established medical use. [6][7]

Graded B (mixed)

GMP and satiety / body weight

Several small trials tested GMP for appetite suppression via cholecystokinin; results inconsistent (Keogh 2010; Veldhorst 2009).

Muscle mass and recovery (hydrolysate vs intact whey)

Hydrolysate shows faster absorption and some trials report faster recovery of force after damaging exercise (Buckley 2010, J Sci Med Sport); for long-term muscle gain, hydrolysate and intact whey perform similarly. [8]

Graded C/D

Antimicrobial, immune, antioxidant

Lactoferricin and other fragments are active and in rodents; no human outcome trials.

4Reported side effects and interactions

Literature-reported

generally well tolerated. Bloating, cramps and diarrhoea, mainly from lactose in less-purified products; hydrolysates taste bitter. Milk-protein allergy is a contraindication. Acne association with whey is reported in observational studies and case series.

Community-reported

digestive upset, bitterness of hydrolysates, acne flare.

Theoretical. high-protein loads in people with advanced kidney disease; GMP products are intended for PKU and are nutritionally incomplete without amino-acid supplementation.

Interactions. whey slows gastric emptying and may delay absorption of co-ingested oral medicines; ACE-inhibitory peptides could theoretically add to prescribed antihypertensives, though the effect is small.

Markers researchers commonly monitor

Marker	Why it's watched
Post-meal glucose (fingerprick or CGM)	the most reproducible human effect is acute glucose blunting.
HbA1c and fasting insulin	for anyone using whey as part of a metabolic protocol over months.
Home blood pressure	if the purpose is the ACE-inhibitory effect; expect small changes at best.
Blood phenylalanine	GMP users with PKU, under clinical supervision.
Kidney function (eGFR, urea)	for very high protein intakes in people with reduced kidney function.
Body composition	if the goal is muscle.

Free for everyone. Safety information is never behind a paywall.

5Formulation and handling

Whey protein hydrolysate is sold as powder (often with flavouring to mask bitterness) and as ingredient in sports and clinical nutrition. Degree of hydrolysis (DH) varies widely and determines both bitterness and peptide profile; two "hydrolysates" can be very different products. GMP for PKU comes as medical foods under dietetic supervision. Store dry; mixed drinks spoil quickly. No calculator applies.

6Commonly studied alongside

Casein-derived peptides (profile 173; the lactotripeptides IPP/VPP are the casein counterparts to lactokinins), leucine, creatine, soy and pea protein hydrolysates (profile 175), GLP-1 agonists as a mechanistic comparator only.

Informational cross-links. Not stack recommendations.

7Regulatory status by region

Region	Status (checked —)
United States	Food / dietary supplement ingredients (GRAS); GMP-based PKU formulas are medical foods
European Union	Food / food supplement; GMP products are foods for special medical purposes; no authorised blood-pressure or glucose health claim for whey peptides †
United Kingdom	As EU
Australia	Food; PKU products are special purpose foods under FSANZ
South Africa	Food / complementary medicine depending on claims
Sport	Not prohibited by WADA

8Open questions

Do lactokinins reach systemic circulation intact at doses people actually consume?
Whether acute glucose effects translate into long-term HbA1c benefit.
Head-to-head trials of hydrolysate versus intact whey on clinical outcomes rather than surrogates.

9References

1FitzGerald RJ, Meisel H (2000). Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr. PubMed · DOI
2Nilsson M et al. (2004). Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins. Am J Clin Nutr. PubMed · DOI
3Frid AH et al. (2005). Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. PubMed · DOI
4Jakubowicz D et al. (2014). Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. PubMed · DOI
5Pal S, Ellis V (2010). The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity. PubMed · DOI
6van Calcar SC et al. (2009). Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids. Am J Clin Nutr. DOI
7Ney DM et al. (2016). Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial. J Inherit Metab Dis. PubMed · DOI
8Buckley JD et al. (2010). Supplementation with a whey protein hydrolysate enhances recovery of muscle force-generating capacity following eccentric exercise. J Sci Med Sport. PubMed · DOI
9Madureira AR et al. (2010). Invited review: physiological properties of bioactive peptides obtained from whey proteins. J Dairy Sci. PubMed · DOI

† Being confirmed by our reviewers against current sources.

10Community

forum threads →

community protocols include this →

Threads and protocols are visible to members. Joining is free.

Self-reported side effects Phase 2

Not enough data yet. 0 of the 50 members needed have logged this compound for 4+ weeks. We don't show anything below 50, so no one can be identified.

11Page history

31 Oct 2026Profile published — awaiting medical review

Licensed CC BY-NC-SA 4.0. Found an error? Report it · Editorial standards — corrections are logged here.